"I want to create figures for a research paper, but I don't know where to start," or "I don't have time to learn specialized software"—these are common concerns heard in medical and life science ...

Anticipation isn’t always about the brains. New research reveals even an animal with no brain at all can anticipate what’s ...

Mahari sits at the front of the boat, cigarette in hand, surveying the conditions of the waters off Poto Tano, a small fishing community on the island of Sumbawa, Indonesia. As ketua, the leader of ...

“Brain cancer” or “H4 G34-mutant”? As knowledge about genetics advances, some doctors say cancers should be defined by their mutations, not the tissues where they manifest.

This is the Japan Nutrition Concierge Association."I am careful about my diet for the sake of my health.""I exercise, and I don't feel unwell at the moment."Even so, can you immediately recall when ...

When local supply runs short, Europe offers a world of choice. Arielle Domb investigates the fast-evolving business of picking, matching and shipping sperm – and the questions behind the hunt for the ...

FAO’s Thanawat Tiensin explains how climate variability, animal movement, underfunded veterinary systems and evolving pest dynamics are reshaping the global biosecurity challenge ...

Health advice is everywhere, yet only a handful of recommendations are repeated so often because they consistently prove useful in real life. These well-known health tips are popular not because they ...

Two new studies from Johns Hopkins University are providing scientists with an unprecedented view of how human cells repair ...

Researchers induced maternal immune activation in pregnant mice and mapped early placental changes. Male fetuses developed placental failure, inflammation, and developmental defects.

Prime editing holds tremendous promise for precise genome engineering, but achieving efficient editing without increasing pegRNA complexity remains a significant challenge. Join this webinar to ...

Abeona Therapeutics (NASDAQ:ABEO) executives outlined the early commercial rollout of ZEVASKYN, an autologous cell ...